The multifaceted bureaucratic delays on public health in the case of the drug clearance crisis in Ghana are growing. The problem at hand is not simply an administrative lapse, but one that affects the lives of countless people who depend on these drugs for survival. This study investigates the impact of bureaucratic delays on the clearance and distribution of life-saving drugs in Ghana, highlighting the resultant effects on public health and the economy. Utilizing a qualitative research design, the research used qualitative data from document analysis and interviews conducted among policymakers, healthcare administrators and international organization representatives with 25 key respondents purposively sampled for the study. The findings revealed significant inefficiencies in the drug clearance process, including redundant paperwork, lack of inter-agency coordination, and prolonged approval times. The study concludes that addressing these bureaucratic delays is crucial for improving health outcomes and economic efficiency in Ghana's healthcare system. By implementing the recommended reforms and inculcating technology, Ghana can enhance the efficiency of its drug clearance processes, ensure timely access to essential medications, and maintain international support.
Copyrights © 2024